1. Impotence.NIH Consensus Development Panel on Impotence;NIH;JAMA,1993
2. Erectile dysfunction;Yafi;Nat Rev Dis Primers,2016
3. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int J Impot Res,1996
4. Sildenafil: Clinical toxicology profile;Krenzelok;J Toxicol Clin Toxicol,2000
5. PDE5 Inhibitor – StatPearls – NCBI Bookshelf. Available form: https://www.ncbi.nlm.nih.gov/books/NBK549843/. [Last accessed on 2021 Jun 07].